Synthesis, Characterization and Antimicrobial Activity of Garcinol Capped Silver Nanoparticles. 2019

H N Fernando, and K G U R Kumarasinghe, and T D C P Gunasekara, and H P S K Wijekoon, and E M A K Ekanayaka, and S P Rajapaksha, and S S N Fernando, and P M Jayaweera
Department of Chemistry, Faculty of Applied Sciences, University of Sri Jayewardenepura 10250, Sri Lanka.

Garcinol, a well-known medicinal phytochemical, was extracted and isolated from the dried fruit rinds of Garcinia quaesita Pierre. In this study, garcinol has successfully used to reduce silver ions to silver in order to synthesize garcinol-capped silver nanoparticles (G-AgNPs). The formation and the structure of G-AgNPs were confirmed by UV-visible spectroscopy, transmission electron microscopy and Fourier transform infrared (FTIR) spectroscopy. The antimicrobial activity of garcinol and G-AgNPs were investigated by well diffusion assays, broth micro-dilution assays and time-kill kinetics studies against five microbial species, including Staphylococcus aureus (ATCC 25923), Pseudomonas aeruginosa (ATCC 27853), Escherichia coli (ATCC 25922), Candida albicans (ATCC 10231) and clinically isolated methicillin-resistant Staphylococcus aureus (MRSA). The formation of G-AgNPs is a promising novel approach to enhancing the biological activeness of silver nanoparticles, and to increase the water solubility of garcinol which creates a broad range of therapeutic applications.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D012834 Silver An element with the atomic symbol Ag, atomic number 47, and atomic weight 107.87. It is a soft metal that is used medically in surgical instruments, dental prostheses, and alloys. Long-continued use of silver salts can lead to a form of poisoning known as ARGYRIA.
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013729 Terpenes A class of compounds composed of repeating 5-carbon units of HEMITERPENES. Isoprenoid,Terpene,Terpenoid,Isoprenoids,Terpenoids
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

H N Fernando, and K G U R Kumarasinghe, and T D C P Gunasekara, and H P S K Wijekoon, and E M A K Ekanayaka, and S P Rajapaksha, and S S N Fernando, and P M Jayaweera
February 2012, Colloids and surfaces. B, Biointerfaces,
H N Fernando, and K G U R Kumarasinghe, and T D C P Gunasekara, and H P S K Wijekoon, and E M A K Ekanayaka, and S P Rajapaksha, and S S N Fernando, and P M Jayaweera
May 2012, Journal of nanoscience and nanotechnology,
H N Fernando, and K G U R Kumarasinghe, and T D C P Gunasekara, and H P S K Wijekoon, and E M A K Ekanayaka, and S P Rajapaksha, and S S N Fernando, and P M Jayaweera
April 2023, Applied biochemistry and biotechnology,
H N Fernando, and K G U R Kumarasinghe, and T D C P Gunasekara, and H P S K Wijekoon, and E M A K Ekanayaka, and S P Rajapaksha, and S S N Fernando, and P M Jayaweera
September 2014, Carbohydrate polymers,
H N Fernando, and K G U R Kumarasinghe, and T D C P Gunasekara, and H P S K Wijekoon, and E M A K Ekanayaka, and S P Rajapaksha, and S S N Fernando, and P M Jayaweera
August 2012, Carbohydrate polymers,
H N Fernando, and K G U R Kumarasinghe, and T D C P Gunasekara, and H P S K Wijekoon, and E M A K Ekanayaka, and S P Rajapaksha, and S S N Fernando, and P M Jayaweera
April 2022, Plants (Basel, Switzerland),
H N Fernando, and K G U R Kumarasinghe, and T D C P Gunasekara, and H P S K Wijekoon, and E M A K Ekanayaka, and S P Rajapaksha, and S S N Fernando, and P M Jayaweera
January 2013, BioMed research international,
H N Fernando, and K G U R Kumarasinghe, and T D C P Gunasekara, and H P S K Wijekoon, and E M A K Ekanayaka, and S P Rajapaksha, and S S N Fernando, and P M Jayaweera
March 2020, Journal of inorganic biochemistry,
H N Fernando, and K G U R Kumarasinghe, and T D C P Gunasekara, and H P S K Wijekoon, and E M A K Ekanayaka, and S P Rajapaksha, and S S N Fernando, and P M Jayaweera
February 2015, Journal of biomedical materials research. Part B, Applied biomaterials,
H N Fernando, and K G U R Kumarasinghe, and T D C P Gunasekara, and H P S K Wijekoon, and E M A K Ekanayaka, and S P Rajapaksha, and S S N Fernando, and P M Jayaweera
January 2018, Artificial cells, nanomedicine, and biotechnology,
Copied contents to your clipboard!